Subjects: Insurance, Pharmaceutical Services -- economics - Digital Collections - National Library of Medicine Search Results

1. State Pharmacy Assistance Programs vs. Medicare prescription drug plans: how do they contain rising costs?

Publication:: [Washington, D.C.] : AcademyHealth, [2005]
Subject(s):: Cost Control
Medicare -- economics
State Health Plans -- economics
Cost Sharing
Drug Costs
Drug Utilization Review
Drugs, Generic
Fees, Pharmaceutical
Formularies as Topic
Insurance Coverage -- legislation & jurisprudence
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Medicare -- legislation & jurisprudence
Humans
United States

2. Calculation of potential inflation-indexed rebates for Medicare Part B drugs

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Cost Control
Cost Savings
Medicaid -- economics
Humans
United States
United States. Department of Health and Human Services.

3. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2017
Subject(s):: Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Prospective Payment System
Abatacept -- economics
Certolizumab Pegol -- economics
Cost Savings
Injections -- economics
Self Care -- economics
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
Healthcare common procedure coding system

4. Prescription drug benefit plans: a buyer's guide

Publication:: [Oakland, Calif.] : California HealthCare Foundation, c2003
Subject(s):: Fees, Pharmaceutical
Insurance, Pharmaceutical Services -- economics
California

5. Impact of Medicare Advantage prescription drug plan star ratings on enrollment before and after implementation of quality-related bonus payments in 2012

Author(s):: Li, Pengxiang, author
Doshi, Jalpa A., author
Publication:: Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2016
Subject(s):: Insurance, Pharmaceutical Services -- economics
Medicare Part C -- economics
Medicare Part C -- utilization
Quality of Health Care
Reimbursement, Incentive
Longitudinal Studies
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

6. Abuse-deterrent formulations of opioids: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
Subject(s):: Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States

11. Seniors and prescription drugs: findings from a 2001 survey of seniors in eight states

Publication:: Washington, D.C. : Henry J. Kaiser Family Foundation ; New York, N.Y. : Commonwealth Fund ; Boston, Mass. ; Tufts-New England Medical Center, [2002]
Subject(s):: Fees, Pharmaceutical
Insurance, Pharmaceutical Services -- economics
Medicaid
Aged
Health Expenditures
Medically Uninsured
United States

12. Medicare Part D and the financial protection of the elderly

Publication:: Chestnut Hill, MA : Center for Retirement Research at Boston College, c2009
Subject(s):: Financing, Personal
Health Expenditures
Insurance, Pharmaceutical Services -- economics
Medicare Part D -- economics
Aged
Drug Utilization
Economic Competition
Insurance Coverage -- statistics & numerical data
Private Sector
Public Sector
Risk
Humans
United States

13. State variation in Medicaid pharmacy benefit use among dual-eligible beneficiaries

Author(s):: Schore, Jennifer.
Publication:: Menlo Park, Calif. : Henry J. Kaiser Family Foundation, c2002
Subject(s):: Fees, Pharmaceutical
Insurance, Pharmaceutical Services -- economics
Medicaid -- economics
Aged
Health Expenditures
United States

14. Indication-specific pricing of pharmaceuticals in the United States health care system: a report from the 2015 ICER Membership Policy Summit

Author(s):: Pearson, Steven D., author
Dreitlein, Bill, author
Henshall, Chris, author
Publication:: Boston, MA : Institute for Clinical and Economic Review, March 2016
Subject(s):: Drug Costs
Economics, Pharmaceutical
Insurance, Pharmaceutical Services -- economics
Prospective Payment System
Reimbursement Mechanisms -- economics
Cost Savings
Cost Sharing
Formularies
Medicaid -- economics
Medicare -- economics
Off-Label Use -- economics
Pilot Projects
Value-Based Purchasing
Humans
United States

15. The Medicare drug benefit coverage gap: the basics

Publication:: Washington, D.C. : George Washington University, [2011]
Subject(s):: Insurance Coverage -- economics
Insurance Coverage -- legislation & jurisprudence
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Drug Costs -- statistics & numerical data
Drug Prescriptions -- economics
Financing, Personal -- economics
Financing, Personal -- legislation & jurisprudence
Humans
United States

16. Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, D.C. : U.S. Government Accountability Office, July 18, 2017
Subject(s):: Government Regulation
Insurance, Pharmaceutical Services -- economics
Medicaid -- economics
Contract Services
Economics, Pharmaceutical
Forecasting
Government Programs -- statistics & numerical data
Insurance, Health, Reimbursement
Pharmacies -- statistics & numerical data
Pharmacies -- trends
Humans
United States
United States. Health Resources and Services Administration.

17. The Medicare prescription drug benefit: potential impact on beneficiaries

Author(s):: Rodgers, Jack (Laban Jackson)
Publication:: Washington, DC : AARP Public Policy Institute, c2004
Subject(s):: Medicare -- economics
Insurance, Pharmaceutical Services -- economics

18. Strategic analysis & intelligence (SAI) report: the tier 4 phenomenon : shifting the high cost of drugs to consumers

Publication:: Washington, D.C. : AARP, [2009]
Subject(s):: Cost Sharing
Deductibles and Coinsurance
Drug Costs
Formularies as Topic
Aged
Insurance, Pharmaceutical Services -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Humans
United States

19. California employer health benefits: workers shoulder more costs

Author(s):: Whitmore, Heidi, author
Gabel, Jon, author
Publication:: Oakland, CA : California Health Care Foundation, June 2018
Subject(s):: Health Benefit Plans, Employee -- economics
Health Benefit Plans, Employee -- statistics & numerical data
Health Benefit Plans, Employee -- trends
Ambulatory Care Facilities
Deductibles and Coinsurance -- statistics & numerical data
Forecasting
Health Maintenance Organizations -- statistics & numerical data
Insurance -- statistics & numerical data
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- statistics & numerical data
Insurance, Pharmaceutical Services -- trends
Managed Care Programs -- economics
Managed Care Programs -- statistics & numerical data
Managed Care Programs -- trends
Small Business -- statistics & numerical data
Telemedicine
State Government
Humans
California
United States

20. Top spenders among commercially-insured: increased spending concentration and consistent turnover from 2013 to 2015

Author(s):: Johnson, Bill, author
Rodriguez, Sally, author
Publication:: Washington, DC : Health Care Cost Institute, February 2018
Subject(s):: Financing, Personal
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Drug Costs
Forecasting
Insurance, Health -- economics
Insurance, Pharmaceutical Services -- economics
Private Sector
Humans
United States

21. Massachusetts Prescription Advantage: an AARP survey

Author(s):: Dinger, Erica.
Publication:: Washington, D.C. : AARP Knowledge Management, c2003
Subject(s):: Fees, Pharmaceutical -- statistics & numerical data
Insurance, Pharmaceutical Services -- economics
Aged
Data Collection -- methods
Public Opinion
Massachusetts

22. Filling the Rx: an analysis of the perceptions and attitudes of Medicare Rx discount card holders

Author(s):: Love, Jeffrey.
Publication:: [Washington, D.C.] : AARP, c2004
Subject(s):: Insurance, Pharmaceutical Services -- economics
Medicare -- economics
United States

23. Filling the Rx: an analysis of the perceptions, attitudes and buying habits of Medicare beneficiaries

Author(s):: Love, Jeffrey.
Publication:: Washington, D.C. : AARP, Knowledge Management, c2004
Subject(s):: Drug Prescriptions -- economics
Insurance, Pharmaceutical Services -- economics
Medicare
Data Collection -- methods
Public Opinion
United States

24. Experiences with and opinions about prescription medication: a survey of AARP members in Delaware

Author(s):: Cicero, David.
Publication:: Washington, D.C. : AARP, Knowledge Management, c2004
Subject(s):: Drug Prescriptions -- economics
Insurance, Pharmaceutical Services -- economics
Data Collection
Health Benefit Plans, Employee -- economics
Public Opinion
Delaware

25. The AARP ads and the new Medicare prescription drug law

Author(s):: Park, Edwin.
Publication:: Washington, D.C. : Center on Budget and Policy Priorities, [2003]
Subject(s):: Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Advertising as Topic
Public Opinion
Drug Prescriptions -- economics
Fees, Pharmaceutical
Medicare -- economics
United States
United States.

26. Prescription drugs in Nebraska: a survey of experiences and opinions

Publication:: Washington, D.C. : AARP Knowledge Management, c2005
Subject(s):: Data Collection
Drug Costs
Drug Prescriptions -- economics
Pharmaceutical Preparations -- economics
Adult
Aged
Insurance, Pharmaceutical Services -- economics
Medical Assistance -- economics
Medicare -- economics
Middle Aged
State Government
Female
Humans
Male
Nebraska
United States

27. 2006 Medicare Advantage benefits and premiums

Publication:: Washington, D.C. : AARP Public Policy Institute, c2006
Subject(s):: Insurance, Pharmaceutical Services -- economics
Medicare -- economics
Cost Sharing
Fee-for-Service Plans -- economics
Forecasting
Health Maintenance Organizations -- economics
Insurance Benefits
Insurance Coverage
Medicare -- trends
Preferred Provider Organizations -- economics
Humans
United States

28. Medicare Part D: a first look at plan offerings in 2016

Author(s):: Hoadley, Jack, author
Cubanski, Juliette, author
Neuman, Tricia, author
Publication:: Menlo Park, CA : Henry J. Kaiser Family Foundation, October 2015
Subject(s):: Insurance Benefits -- economics
Insurance Benefits -- statistics & numerical data
Insurance Coverage -- economics
Insurance Coverage -- statistics & numerical data
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- statistics & numerical data
Medicare Part D -- economics
Medicare Part D -- statistics & numerical data
United States

29. Medicaid's most costly outpatient drugs

Author(s):: Young, Katherine, author
Rudowitz, Robin, author
Garfield, Rachel, author
Musumeci, MaryBeth, author
Publication:: Menlo Park, CA : Henry J. Kaiser Family Foundation, July 2016
Subject(s):: Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicaid -- economics
Prescription Drugs -- economics
United States